MILLENNIUM MANAGEMENT LLC - BRIDGEBIO PHARMA INC ownership

BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 205 filers reported holding BRIDGEBIO PHARMA INC in Q1 2021. The put-call ratio across all filers is 1.92 and the average weighting 0.8%.

Quarter-by-quarter ownership
MILLENNIUM MANAGEMENT LLC ownership history of BRIDGEBIO PHARMA INC
ValueSharesWeighting
Q3 2023$12,289,844
+136.1%
466,054
+54.0%
0.01%
+100.0%
Q2 2023$5,206,440
+75873.2%
302,700
-26.8%
0.00%
-25.0%
Q1 2023$6,853
+969.1%
413,369
+391.1%
0.00%
Q4 2022$641
-100.0%
84,177
-92.8%
0.00%
-100.0%
Q3 2022$11,583,000
+111.9%
1,165,308
+93.6%
0.01%
+133.3%
Q2 2022$5,465,000
-47.1%
601,867
-40.9%
0.00%
-50.0%
Q1 2022$10,331,000
-60.7%
1,017,809
-35.4%
0.01%
-57.1%
Q4 2021$26,289,000
+136.5%
1,576,073
+564.4%
0.01%
+100.0%
Q3 2021$11,118,000
+29.3%
237,215
+68.2%
0.01%
+40.0%
Q2 2021$8,596,000
+233.6%
141,011
+237.0%
0.01%
+150.0%
Q1 2021$2,577,000
-64.3%
41,842
-58.8%
0.00%
-60.0%
Q4 2020$7,214,000
+457.5%
101,442
+155.7%
0.01%
+150.0%
Q2 2020$1,294,000
-81.1%
39,680
-83.2%
0.00%
-86.7%
Q1 2020$6,850,000
+754.1%
236,200
+531.9%
0.02%
+1400.0%
Q3 2019$802,000
-92.2%
37,382
-90.2%
0.00%
-93.3%
Q2 2019$10,246,000379,9190.02%
Other shareholders
BRIDGEBIO PHARMA INC shareholders Q1 2021
NameSharesValueWeighting ↓
Aisling Capital Management LP 6,068,125$160,016,45665.94%
Kohlberg Kravis Roberts & Co. L.P. 31,060,971$819,077,80528.79%
Cormorant Asset Management, LP 4,662,530$122,950,9167.17%
Frazier Life Sciences Management, L.P. 2,725,949$71,883,2754.77%
Octagon Capital Advisors LP 971,639$25,622,1203.94%
M28 Capital Management LP 121,200$3,196,0443.66%
VIKING GLOBAL INVESTORS LP 25,120,991$662,440,5332.69%
BOONE CAPITAL MANAGEMENT LLC 313,381$8,263,8572.61%
Fernwood Investment Management, LLC 235,620$6,213,2992.23%
SOUTHPORT MANAGEMENT, L.L.C. 15,000$395,5502.15%
View complete list of BRIDGEBIO PHARMA INC shareholders